All the news Showing 10 of 44 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Heavy drinking endangers the health of liver transplants Liver Disease News from Medical News Today / 06 April 2016 U.S. FDA Approves Two Supplemental Indications for Harvoni® in Chronic Hepatitis C Patients With Advanced Liver Disease Gilead press release / 17 February 2016 Johns Hopkins approved to perform first HIV-positive to HIV-positive organ transplants in U.S. Johns Hopkins Medicine / 09 February 2016 U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Bristol-Myers Squibb press release / 08 February 2016 Olysio/Sovaldi yield high SVR post-liver transplant Healio / 08 February 2016 European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV Bristol-Myers Squibb press release / 01 February 2016 HCV at a Crossroads:The Pre- or Post-Transplant Treatment Debate Healio HCV Next / 15 June 2015 HIV did not affect HCC recurrence or survival after liver transplant Healio Hepatology / 04 March 2015 Adherence to drug regimen by liver transplant patients hindered by limited literacy, more meds Liver Disease News from Medical News Today / 13 January 2015 Interferon-free combination therapy prevents recurrence of HCV after liver transplantation Manual Items / 09 January 2015 ← Prev12345Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive